MSF refuses to sign ViiV’s NDA for access to lifesaving HIV prevention drug

CORRESPONDENT NEW YORK/GENEVA, AUGUST 17, 2023—Doctors Without Borders/Médecins Sans Frontières (MSF) is asking today for the removal of last-minute terms that ViiV Healthcare has added to an agreement to procure the injectable HIV prevention drug long-acting cabotegravir (CAB-LA) for use in MSF projects. These unacceptable conditions include a confidentiality clause akin to a Non-Disclosure Agreement…